Hepatitis

;

President Trump Must Restore “Ending the HIV Epidemic” funding & other domestic HIV programs

Apr 25, 2025

“We hope this is one of those instances of ‘mistakes will be made’ and urge President Trump to include funding in his budget to maintain our nation’s HIV response to keep Americans healthy. During his first term, President Trump realized that although we have the tools to end HIV through innovative treatment and prevention medications, the results remained relatively stagnant and by efficiently investing resources in the communities with the highest number of infections, over time we can end HIV. The initiative, which builds upon the existing CDC prevention and Ryan White HIV/AIDS treatment programs, has demonstrated success with a 21-percent reduction in HIV incidence in those jurisdictions that received enhanced funding compared to a 6-percent drop in those that did not. This resulted in 9,500 fewer infections, which saved $5.1 billion in lifetime medical costs.

read more

Statement on elimination of HHS Office of Infectious Diseases & HIV Policy & Other HHS staff cuts

Mar 28, 2025

Today the Trump administration continued its decimation of our nation’s response not only to HIV, but to hepatitis and STIs. While we wait to learn specifics on how many staff who support CDC’s HIV and hepatitis prevention programs will be eliminated, all staff at the government’s central coordinating office which develops strategic plans, coordinates agency actions, collects and communicates vital data, administers the Ending the HIV Epidemic initiative, and oversees the Presidential Advisory Council on HIV/AIDS, have been fired.

read more

20 HIV & hepatitis organizations urge the U.S. Supreme Court to protect preventive services coverage

Feb 25, 2025

“Coverage of no-cost preventive services, including HIV and hepatitis testing, along with PrEP, now rests with the highest court in the land. In our brief we laid out the critical role testing plays in linking people to life-saving medications and, in the case of hepatitis C, curative treatment, along with the importance of people knowing if they have an infectious disease. We describe the growing importance of PrEP in preventing HIV, including long-acting PrEP drugs which are almost 100 percent effective in preventing HIV,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We emphasize that coverage of preventive services by private insurers will help end HIV and hepatitis and losing them would certainly damage the public health of our country and increase medical costs.”

read more

HIV+Hepatitis Policy Institute comments on 2024 election results

Nov 6, 2024

The American people have spoken and elected Donald Trump and JD Vance as our next President and Vice President. The HIV+Hepatitis Policy Institute will work with the new administration on furthering efforts to end HIV and hepatitis in the United States. With proper leadership, policies, and funding, we can end both these infectious diseases.

read more

Biden budget maintains domestic HIV funding & proposes PrEP & hepatitis C programs

Mar 11, 2024

“While we appreciate the proposed continued funding of  domestic HIV and hepatitis programs and acknowledge the legislatively imposed budget constraints and competing priorities, the reality is that, without serious increases, our nation cannot meet its goals to end the HIV and hepatitis epidemics on time,” commented Carl Schmid, Executive Director of the HIV+Hepatitis Policy Institute. “Now, we must take our case for any funding increases to Congress, which has found it difficult to agree on spending bills, and House Republicans have even proposed to cut domestic HIV spending this year by $767 million.”

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest